EU Approves Sales of Sanofi’s New Diabetes Drug

29.04.2015 - The European Commission has granted marketing authorization in Europe for Sanofi's Toujeo, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus...